Midgard Science
O

Ordaos

New York, NY, United States ordaos.bio From their website, Nov 2026

Work here? Claim this listing

About

Ordaos designs small proteins and biologics using an AI-driven, lab-in-the-loop platform. It works with partners on rapid discovery and optimization programs for therapeutics and related protein applications from its site in Long Island City, New York.

Ordaos is based in New York, NY. It lists 7 services, including AI-driven protein design, Rapid lab-in-the-loop testing and Mini-protein discovery.

Services

  • AI-driven protein design

    Uses a multi-agentic LLM system to generate and screen novel protein designs.

  • Rapid lab-in-the-loop testing

    Makes and tests candidate proteins in its proprietary cell-free protein expression system and runs them through laboratory assays.

  • Mini-protein discovery

    Rapidly discovers high-value small protein candidates, including de novo mini-proteins and miniPRO binders.

  • Protein optimization

    Optimizes existing protein formats such as VHH antibodies using generative AI.

  • De novo mini-protein design

    Creates novel mini-proteins from scratch using its Design Engine and AI-driven sequence and structure generation.

  • Single domain antibody optimization

    Optimizes single domain VHH antibodies for target binding and developability using generative AI.

  • Therapeutic candidate design for target profiles

    Translates human-defined molecular target product profiles into designed miniPRO candidates.

Turnaround
  • 5 days
  • Within weeks

How to order from Ordaos

Turnaround they state: 5 days; Within weeks. They take requests through the contact form on their website. You can contact them directly from this page, or request a quote through Midgard.

Capabilities

Assays and studies
  • Antibodies
  • Immunogenicity
  • Binding affinity
  • Binding kinetics
  • Binding durability
  • Off-target interactions
14 more
  • Thermal stability
  • Chemical stability
  • Structural integrity
  • Freeze-thaw resilience
  • Oxidation resistance
  • Shear stress tolerance
  • Cytotoxicity
  • Accumulation risk
  • Allergenic potential
  • Metabolite toxicity
  • Binding specificity
  • Solubility
  • Stability
  • Developability
Scale and capacity
200 mini-proteins per round
Therapeutic areas
  • Metabolic disorder
  • Infectious disease
  • NTM
  • Drug discovery
  • Therapeutics

Modalities and species

Modalities
Antibody
Species and models
Cell-free protein expression system

Details

Address
228 Park Ave S 60684, New York, NY 10003, USA
Sites
Long Island City, USA

Similar labs